SOCS3 and asthma: Draijer et al. showed that extracellular vesicles synthesized by resident alveolar macrophages, containing cytokine signaling suppressor 3 (SOCS3), could inhibit inflammatory signaling in alveolar epithelial cells while synthetic liposomes containing SOCS3 restore this inflammatory suppression effect when impaired in case of asthma [152].